PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Based in London, Several is a menswear brand with firm roots in British sub-culture. Several's clothing focuses on quality, craftsmanship, and luxury. The funds raised will be used to open a store in London and to grow sales.
days to go:
Expired
investment:
£7,350
Urban is a wellness app that allows customers to book massages, beauty treatments, personal training and more at the customer's doorstep in 60 minutes. The company's practitioners are already operating in London, Paris, Manchester and Birmingham covering all aspects of wellness, from massage to mindfulness and beyond. Urban has delivered over 650,000 appointments till date, witnessed £43 million in cumulative sales value since August 2018, onboarded 3,800 partner practitioners, and saw 7,300+ reviews on Apple app store with an average rating of 4.8/5 stars. It will use the investment to drive towards Operating Expense (OpEx) profitability by the end of Q1 2021, reach EBITDA positive by the end of 2021, and scale into new markets through remote expansion.
days to go:
Expired
investment:
£5,877,517
Chapel Down (CD) is one of the UK's leading wine industry leaders that seeks to challenge the hegemony of champagne. It argues that with the sales of English sparkling wine forecast to grow by 134% by 2026, the demand for its products is growing fast. CD's 'Sparkling Wine' sales increased by 52.8% in 2020 whilst champagne sales in the UK dropped by 21.7% over the same period. The company argues that 2020 was a record year for its business, despite COVID-19, with its revenue growing by 32% year on year and e-commerce sales growing by 467% year on year. CD has partnered with notable hospitality entities like Harrods, Royal Opera House and Sheraton Grand. It will use the investment to scale up and improve its winemaking capabilities, complete the planting process of its biggest vineyard on the finest terroir in England, scale up its e-commerce channels, invest in selected export markets worldwide, and give people a memorable experience at its winery.
days to go:
Expired
investment:
£6,953,241
JOHNNY'S is a sex-positive condom brand. It asserts that conventional condoms are overpriced, often unethically made harming both humans and animals, with the buying process being an awkward experience. It aims to change this via its condoms that are vegan, compostable, of high quality and packaged as sustainably as possible. The company intends to deliver its products on a subscription basis, similar to Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aspires to become a contender in the global condom market that is set to be worth $15 billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go:
Expired
investment:
£219,819
Bioepic is an app which enables users to easily and non-invasively measure their health status in just 30 seconds using just a smartphone. The app calculates pulse wave velocity, body temperature, blood pressure, heart rate variability chaos, vascular stiffness and the effectiveness of inhalers.
days to go:
Expired
investment:
£12,500
Gozney specialises in the designing and manufacturing of premium and creative stone & fire ovens for the commercial and home use. The company has invented the world’s first portable stone pizza oven, 'Roccbox' and made $1.2M pre-sales in 45 days. In 2018-19, it has received revenue of £5.4M and EBITDA of £0.2M. Gozney ovens are used by leading restaurant chains including MOD, Franco Manca and many more. Recently, the company has been ranked at No. 12 in the 5th annual Sunday Times WorldFirst SME Export Track 100. Gozney has witnessed a growth of 148% in international sales over the past 2 years. Furthermore, it aims to launch new products and accelerate expansion into overseas territories.
days to go:
Expired
investment:
£1,716,200
